221 related articles for article (PubMed ID: 21969325)
1. Modulation of peripheral sensory neurons by the immune system: implications for pain therapy.
Stein C; Machelska H
Pharmacol Rev; 2011 Dec; 63(4):860-81. PubMed ID: 21969325
[TBL] [Abstract][Full Text] [Related]
2. Opioids and sensory nerves.
Stein C; Zöllner C
Handb Exp Pharmacol; 2009; (194):495-518. PubMed ID: 19655116
[TBL] [Abstract][Full Text] [Related]
3. Targeting of opioid-producing leukocytes for pain control.
Machelska H
Neuropeptides; 2007 Dec; 41(6):355-63. PubMed ID: 17640727
[TBL] [Abstract][Full Text] [Related]
4. Peripherally acting opioids and clinical implications for pain control.
Sehgal N; Smith HS; Manchikanti L
Pain Physician; 2011; 14(3):249-58. PubMed ID: 21587328
[TBL] [Abstract][Full Text] [Related]
5. Opioid receptors and opioid peptide-producing leukocytes in inflammatory pain--basic and therapeutic aspects.
Busch-Dienstfertig M; Stein C
Brain Behav Immun; 2010 Jul; 24(5):683-94. PubMed ID: 19879349
[TBL] [Abstract][Full Text] [Related]
6. Leukocytes in the regulation of pain and analgesia.
Rittner HL; Machelska H; Stein C
J Leukoc Biol; 2005 Dec; 78(6):1215-22. PubMed ID: 16204636
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the peripheral sensory and sympathetic nervous system in the vascular endothelial expression of ICAM-1 and the recruitment of opioid-containing immune cells to inhibit inflammatory pain.
Mousa SA; Shaqura M; Brendl U; Al-Khrasani M; Fürst S; Schäfer M
Brain Behav Immun; 2010 Nov; 24(8):1310-23. PubMed ID: 20600813
[TBL] [Abstract][Full Text] [Related]
8. Peripheral mechanisms of opioid analgesia.
Stein C; Lang LJ
Curr Opin Pharmacol; 2009 Feb; 9(1):3-8. PubMed ID: 19157985
[TBL] [Abstract][Full Text] [Related]
9. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of peripheral immune-cell-mediated analgesia in inflammation: clinical and therapeutic implications.
Hua S; Cabot PJ
Trends Pharmacol Sci; 2010 Sep; 31(9):427-33. PubMed ID: 20591509
[TBL] [Abstract][Full Text] [Related]
11. Neurokinin-1 receptor antagonists inhibit the recruitment of opioid-containing leukocytes and impair peripheral antinociception.
Rittner HL; Lux C; Labuz D; Mousa SA; Schäfer M; Stein C; Brack A
Anesthesiology; 2007 Dec; 107(6):1009-17. PubMed ID: 18043070
[TBL] [Abstract][Full Text] [Related]
12. Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy.
Rice AS; Farquhar-Smith WP; Nagy I
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):243-56. PubMed ID: 12052040
[TBL] [Abstract][Full Text] [Related]
13. Opioids for the treatment of arthritis pain.
Stein C; Baerwald C
Expert Opin Pharmacother; 2014 Feb; 15(2):193-202. PubMed ID: 24283649
[TBL] [Abstract][Full Text] [Related]
14. Peripherally-acting opioids.
Smith HS
Pain Physician; 2008 Mar; 11(2 Suppl):S121-32. PubMed ID: 18443636
[TBL] [Abstract][Full Text] [Related]
15. Attacking pain at its source: new perspectives on opioids.
Stein C; Schäfer M; Machelska H
Nat Med; 2003 Aug; 9(8):1003-8. PubMed ID: 12894165
[TBL] [Abstract][Full Text] [Related]
16. Pain control by immune-derived opioids.
Machelska H; Stein C
Clin Exp Pharmacol Physiol; 2000 Jul; 27(7):533-6. PubMed ID: 10874513
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of cannabinoid receptor ligands: current status.
Singh J; Budhiraja S
Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):177-83. PubMed ID: 16810344
[TBL] [Abstract][Full Text] [Related]
18. Immune cell-mediated opioid analgesia.
Machelska H; Celik MÖ
Immunol Lett; 2020 Nov; 227():48-59. PubMed ID: 32814155
[TBL] [Abstract][Full Text] [Related]
19. Control of neuropathic pain by immune cells and opioids.
Machelska H
CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):559-70. PubMed ID: 21631408
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid receptors and their ligands.
Pertwee RG; Ross RA
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):101-21. PubMed ID: 12052030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
